The study findings may spark treatment innovations for depression and anxiety.

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A DNA test could help match patients with psychiatric medications, potentially reducing the long and frustrating ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...

Amanda Miller was 30 and pregnant with her second child in Hershey, Pennsylvania, when she developed depression. After she gave birth, her depression worsened. It was joined by a slew of unexplained ...

This week, Mad in America examines three studies around mental health diagnosis, psychotropic drug use, obesity, and diabetes ...

New research shows that people who take certain psychiatric medications may be more likely to develop amyotrophic lateral sclerosis (ALS), which is the most common form of motor neurone disease (MND).

We are all living through challenging and unprecedented times, and rates of depression and anxiety are at an all-time high. Fortunately, in the era of telehealth, access to care from the safety of one ...

Health Secretary Robert F. Kennedy Jr. recently said that the diet could “cure” schizophrenia. We asked experts about the ...

Women face steeper out-of-pocket costs for mental health care than men. In 2024, women spent a staggering $5.4 billion out of pocket on treatment for mental health conditions, compared to $3.6 billion ...